Nakamura Yoki, Matsuda Riku, Kuribayashi Shogo, Takemura Masatoshi, Hisaoka-Nakashima Kazue, Morioka Norimitsu
Department of Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
J Neurochem. 2025 Jun;169(6):e70139. doi: 10.1111/jnc.70139.
The subcellular localization and cellular functions of the microglial α7-nicotinic acetylcholine receptor (α7-nAChR) were investigated in detail. Although α7-nAChR mRNA was present in microglia isolated from mouse brains by fluorescence-activated cell sorting, we observed low levels of mRNA for NACHO (novel acetylcholine receptor chaperone) and RIC3 (resistance to inhibitors of cholinesterase 3), which are crucial chaperones for the functional expression of α7-nAChR as an ionotropic receptor. Limited localization of α7-nAChR on the cell membrane of isolated microglia suggested an intracellular distribution of this receptor preferentially. To examine the function of α7-nAChR as a ligand-gated ion channel receptor, we treated primary cultured microglia with the α7-nAChR agonist choline; however, no increase in the intracellular calcium ion concentration was observed. Cell staining with α-bungarotoxin and an α7-nAChR antibody suggested that the α7-nAChR expressed in microglia is localized intracellularly, particularly in mitochondria, rather than at the cell membrane. Treatment of primary cultured microglia with choline significantly increased intracellular ATP levels, an indicator of mitochondrial function. This increase in ATP production was significantly suppressed by pretreatment with the α7-nAChR antagonist methyllycaconitine. In microglia with relatively low expression levels of NACHO and RIC3, the population of α7-nAChRs functioning as ion channel receptors at the plasma membrane is expected to be limited. This study reveals a newly described cellular function of microglial α7-nAChR in mitochondria. This finding improves our understanding of the multifaceted roles of α7-nAChRs in the central nervous system and opens new avenues for exploring their potential as a therapeutic target in microglia-related central nervous system disorders.
对小胶质细胞α7-烟碱型乙酰胆碱受体(α7-nAChR)的亚细胞定位和细胞功能进行了详细研究。虽然通过荧光激活细胞分选从小鼠脑中分离出的小胶质细胞中存在α7-nAChR mRNA,但我们观察到NACHO(新型乙酰胆碱受体伴侣)和RIC3(抗胆碱酯酶3)的mRNA水平较低,它们是α7-nAChR作为离子型受体功能表达的关键伴侣。分离出的小胶质细胞膜上α7-nAChR的定位有限,这表明该受体优先分布在细胞内。为了研究α7-nAChR作为配体门控离子通道受体的功能,我们用α7-nAChR激动剂胆碱处理原代培养的小胶质细胞;然而,未观察到细胞内钙离子浓度增加。用α-银环蛇毒素和α7-nAChR抗体进行细胞染色表明,小胶质细胞中表达的α7-nAChR定位于细胞内,特别是线粒体中,而不是细胞膜上。用胆碱处理原代培养的小胶质细胞显著提高了细胞内ATP水平,这是线粒体功能的一个指标。ATP产生的这种增加被α7-nAChR拮抗剂甲基lycaconitine预处理显著抑制。在NACHO和RIC3表达水平相对较低的小胶质细胞中,在质膜上作为离子通道受体发挥作用的α7-nAChR群体预计是有限的。本研究揭示了小胶质细胞α7-nAChR在线粒体中的一种新描述的细胞功能。这一发现增进了我们对α7-nAChRs在中枢神经系统中多方面作用的理解,并为探索它们作为小胶质细胞相关中枢神经系统疾病治疗靶点的潜力开辟了新途径。